We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
American Integrity Insurance
AII
$572M
| $9.25M | 0.06% |
491,272
-67,925
| -12% | -$1.23M |
2025 Q2
4 quarters
|
|
302
Teleflex
TFX
$5.79B
| $9.07M | 0.06% |
71,554
-224,933
| -76% | -$28.8M |
2024 Q4
6 quarters
|
|
303
Curtiss-Wright
CW
$17.5B
| $8.9M | 0.06% |
+11,749
| New | +$8.61M |
2026 Q2
0 quarters
|
|
304
Toro Company
TTC
$10B
| $8.74M | 0.06% |
89,734
-302,760
| -77% | -$28.2M |
2025 Q1
5 quarters
|
|
305
Baldwin Insurance Group
BWIN
$4.49B
| $8.71M | 0.06% |
+327,679
| New | +$7.08M |
2026 Q2
0 quarters
|
|
306
Graco
GGG
$11.2B
| $8.61M | 0.06% |
113,928
+69,198
| +155% | +$5.46M |
2025 Q2
4 quarters
|
|
307
ANI Pharmaceuticals
ANIP
$1.69B
| $8.39M | 0.05% |
101,332
-152,898
| -60% | -$12.3M |
2024 Q4
6 quarters
|
|
308
Monolithic Power Systems
MPWR
$57.4B
| $8.18M | 0.05% |
5,914
-9,101
| -61% | -$13.7M |
2025 Q4
2 quarters
|
|
309
Pfizer
PFE
$173B
| $8.08M | 0.05% |
335,530
+254,644
| +315% | +$6.66M |
2025 Q4
2 quarters
|
|
310
Fervo Energy
FRVO
$2.43B
| $8.08M | 0.05% |
+276,335
| New | +$10M |
2026 Q2
0 quarters
|
|
311
Hinge Health
HNGE
$8.87B
| $8.02M | 0.05% |
96,612
-43,320
| -31% | -$2.35M |
2026 Q1
1 quarter
|
|
312
KB Home
KBH
$2.81B
| $7.99M | 0.05% |
127,705
-624,127
| -83% | -$32.5M |
2025 Q3
3 quarters
|
|
313
Altria Group
MO
$127B
| $7.88M | 0.05% |
109,549
-959,772
| -90% | -$67M |
2026 Q1
1 quarter
|
|
314
Janus Living Inc
JAN
$6.71B
| $7.66M | 0.05% |
266,547
+66,547
| +33% | +$1.73M |
2026 Q1
1 quarter
|
|
315
Vistra
VST
$47.3B
| $7.61M | 0.05% |
+47,957
| New | +$7.44M |
2026 Q2
0 quarters
|
|
316
Onto Innovation
ONTO
$9.7B
| $7.38M | 0.05% |
19,492
-77,017
| -80% | -$21.8M |
2026 Q1
1 quarter
|
|
317
Teladoc Health
TDOC
$1.15B
| $7.34M | 0.05% |
865,349
-644,605
| -43% | -$4.29M |
2026 Q1
1 quarter
|
|
318
First Solar
FSLR
$18.4B
| $7.18M | 0.05% |
30,449
+30,117
| +9,071% | +$7.06M |
2025 Q4
2 quarters
|
|
319
UMB Financial
UMBF
$10.3B
| $7.16M | 0.05% |
50,160
| – | – |
2026 Q1
1 quarter
|
|
320
Southern Company
SO
$108B
| $7.14M | 0.05% |
+74,550
| New | +$7.02M |
2026 Q2
0 quarters
|
|
321
Celcuity
CELC
$3.21B
| $7.1M | 0.05% |
67,907
-2,629
| -4% | -$303K |
2026 Q1
1 quarter
|
|
322
NVIDIA
NVDA
$5.12T
| $7.04M | 0.05% |
+35,160
| New | +$7.23M |
2026 Q2
0 quarters
|
|
323
Option Care Health
OPCH
$4.69B
| $7.01M | 0.05% |
334,125
-905,448
| -73% | -$21.1M |
2025 Q4
2 quarters
|
|
324
Lincoln International
LCLN
$857M
| $6.71M | 0.04% |
+281,100
| New | +$6.63M |
2026 Q2
0 quarters
|
|
325
Marqeta
MQ
$2.01B
| $6.6M | 0.04% |
+406,569
| New | +$6.61M |
2026 Q2
0 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.